Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones

DOI: 10.1248/cpb.32.2773

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 2565 - 2570 (1984)

Update date:2022-09-26

Topics:

Authors:

Akimoto Akimoto

Kawai Kawai

Hashimoto

Nomura Nomura

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.32.2773

Full text of DOI:10.1248/cpb.32.2773

NII-Electronic Library Service

Products guided by the article

Product name:3-epimaytansinol 3-phenylacetate

Cas No:72887-70-8

R&D Labs maybe for 72887-70-8

Zha Yan

Contact:+86-13914766747

Address:Floors 21&22, Jin Cheng Tower, No. 216 Middle Longpan Road, Nanjing
Lanling Hongchuang Flame Retardant Co., Ltd.

Contact:+86-531-68858132

Address:East Huafeichang Road, Cangshan County, Linyi, Shandong, China (Mainland)
Shandong Xinke Petrochemical Co., Ltd.

Contact:+86-546-7277016

Address:Gudao Industrial Park, Hekou District, Dongying, Shandong Province, China
Greenutra Resource Inc

website:http://www.greenutra.cn

Contact:0086-411-39553357

Address:No. 7-1-1802, Huizhi Garden,Ocean Square,Dalian, 116033, China
jiangsu senxuan pharmaceutical and chemical co.,ltd

Contact:86-523-87982810

Address:hongqiao industrial zone,taixing,jiangsu china

Relevant to this article

DABCO-mediated decarboxylative cyclization of isatoic anhydride with aroyl/heteroaroyl/alkoylacetonitriles under microwave conditions: Strategy for the synthesis of substituted 4-quinolones

Doi:10.1016/j.tetlet.2021.153187
(2021)
Site- And enantiodifferentiating C(sp³)-H oxidation enables asymmetric access to structurally and stereochemically diverse saturated cyclic ethers

Doi:10.1021/jacs.0c09636
(2020)
Doi:10.1021/jo01017a020
(1965)
ACID-CATALYSED MONOACETYLATION OF TWO 3-DEOXYHEXITOLS

Doi:10.1016/0008-6215(80)90004-X
(1980)
Development of a Strategy for Convergent Total Synthesis of the Aureolic Acid Antitumor Antibiotics

Doi:10.1021/jo00142a009
(1982)
Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: Discovery of deleobuvir (BI 207127)

Doi:10.1021/jm4011862
(2014)

Article Doi